Radial artery sclerostin expression in chronic kidney disease stage 5 predialysis patients: a cross-sectional observational study
Author:
Funder
Youth Talent Programme of Changzhou Government Healthy Service
Publisher
Springer Science and Business Media LLC
Subject
Urology,Nephrology
Link
http://link.springer.com/article/10.1007/s11255-017-1604-0/fulltext.html
Reference24 articles.
1. Russo D, Corrao S, Battaglia Y et al (2011) Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis. Kidney Int 80(1):112–118
2. Gauthier-Bastien A, Ung RV, Larivière R et al (2014) Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease. Clin Exp Hypertens 36(3):173–180
3. Davies MR, Hruska KA (2001) Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 60(2):472–479
4. Demer LL, Tintut Y (2008) Vascular calcification: pathobiology of a multifaceted disease. Circulation 117(22):2938–2948
5. Gaudio A, Privitera F, Battaglia K et al (2012) Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2diabetes mellitus. J Clin Endocrinol Metab 97(10):3744–3750
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Updates in the chronic kidney disease-mineral bone disorder show the role of osteocytic proteins, a potential mechanism of the bone—Vascular paradox, a therapeutic target, and a biomarker;Frontiers in Physiology;2023-01-26
2. Role of Sclerostin in Cardiovascular Disease;Arteriosclerosis, Thrombosis, and Vascular Biology;2022-07
3. Serum Sclerostin Levels and Mortality in Hemodialysis Patients: An 8-Year Prospective Study;American Journal of Nephrology;2022
4. Cardiovascular Safety of Anti-Sclerostin Therapy in Chronic Kidney Disease;Metabolites;2021-11-10
5. Anti-Sklerostin-Therapie aus nephrologischer Sicht – mit einem Fokus auf kardiovaskuläre Sicherheit;Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen;2021-08-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3